|
pubmed:abstractText |
??-agonists, the most common treatment for asthma, have a wide interindividual variability in response, which is partially attributed to genetic factors. We previously identified single nucleotide polymorphisms in the arginase 1 (ARG1) gene, which are associated with ??-agonist bronchodilator response (BDR).
|
